SCOPUS 정보 검색 플랫폼

Clinical and Experimental Pharmacology and Physiology

Volumn 28, Issue 11, 2001, Pages 905-912

Design of clinical pharmacology trials

(1) Duffull, S B a

a UNIVERSITY OF QUEENSLAND (Australia)

Author keywords

Cross over design; Monte Carlo simulation; Optimal design; Pharmacokinetics; Population analysis

Indexed keywords

ANALYTIC METHOD; CLINICAL PHARMACOLOGY; CLINICAL TRIAL; CONFERENCE PAPER; EVALUATION; INTERMETHOD COMPARISON; MATHEMATICAL MODEL; METHODOLOGY; SYSTEM ANALYSIS;

CLINICAL TRIALS; COMPUTER SIMULATION; CROSS-OVER STUDIES; HUMANS; MONTE CARLO METHOD; PHARMACOLOGY, CLINICAL; RESEARCH DESIGN;

EID: 0035174532 PISSN: 03051870 EISSN: None Source Type: Journal
DOI: 10.1046/j.1440-1681.2001.03546.x Document Type: Conference Paper

Times cited : (7)

References (38)

1
- 0030940891
- Drug development: Improving the process
- (1997) Food Drug Law J. , vol.52 , pp. 163-167
- Peck, C.C.¹

2
- 0031003468
- Learning versus confirming in clinical drug development
- (1997) Clin. Pharmacol. Ther. , vol.61 , pp. 275-291
- Sheiner, L.B.¹

3
- 0033437188
- Population modelling in drug development
- (1999) Stat. Meth. Med. Res. , vol.8 , pp. 183-193
- Sheiner, L.¹ Wakefield, J.²

4
- 0003484780
- Cambridge University Press, Cambridge
- (1997) Bootstrap Methods and Their Application
- Davison, A.C.¹ Hinkley, D.V.²

5
- 0003834625
- Centre for Drug Development Science, Washington, DC
- (1999) Simulation in Drug Development: Good Practices Draft, Version 1.0
- Holford, N.H.G.¹ Hale, M.² Ko, H.C.³ Steimer, J.-L.⁴ Sheiner, L.B.⁵ Peck, C.C.⁶

6
- 0034074181
- Simulation of clinical trials
- (2000) Annu. Rev. Pharmacol. Toxicol. , vol.40 , pp. 209-234
- Holford, N.H.G.¹ Kimko, H.C.² Monteleone, J.P.R.³ Peck, C.C.⁴

7
- 0034119297
- Pharmacokinetic/pharmacodynamic modeling in drug development
- (2000) Annu. Rev. Pharmacol. Toxicol. , vol.40 , pp. 67-95
- Sheiner, L.B.¹ Steimer, J.-L.²

8
- 0025836658
- Population kinetics: Theory and practice
- (1991) Br. J. Clin. Pharmacol. , vol.32 , pp. 669-670
- Aarons, L.¹

9
- 0022489531
- Population pharmacokinetics: Theory and clinical application
- (1986) Clin. Pharmacokinet. , vol.11 , pp. 387-407
- Whiting, B.¹ Kelman, A.W.² Grevel, J.³

10
- 0032769235
- Population pharmacokinetics. A regulatory perspective
- (1999) Clin. Pharmacokinet. , vol.37 , pp. 41-58
- Sun, H.¹ Fadiran, E.O.² Jones, C.D.³

11
- 0033435139
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- (1999) Stat. Meth. Med. Res. , vol.8 , pp. 217-245
- Machado, S.G.¹ Miller, R.² Hu, C.³

12
- 0034109599
- A pharmacokinetic simulation model for ivabradine in healthy volunteers
- (2000) Eur. J. Pharm. Sci. , vol.10 , pp. 285-294
- Duffull, S.B.¹ Chabaud, S.² Nony, P.³ Laveille, C.⁴ Girard, P.⁵ Aarons, L.⁶

13
- 0034031958
- Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteers
- (2000) Eur. J. Pharm. Sci. , vol.10 , pp. 275-284
- Duffull, S.B.¹ Aarons, L.²

14
- 0033454017
- The impact of compliance in pharmacokinetics studies
- (1999) Stat. Meth. Med. Res. , vol.8 , pp. 247-262
- Vrijens, B.¹ Goetghebeur, E.²

15
- 0027092348
- A computationally efficient approach for the design of population studies
- (1992) J. Pharmacokinet. Biopharm. , vol.20 , pp. 279-294
- Wang, J.¹ Endrenyi, L.²

16
- 0025081107
- Experimental design and efficient parameter estimation in population pharmacokinetics
- (1990) J. Pharmacokinet. Biopharm. , vol.18 , pp. 347-360
- Albana, M.K.¹ Kelman, A.W.² Whiting, B.³

17
- 4243336084
- PhD Thesis, University of Edinburgh, Edinburgh
- (2001) Optimisation of study design in the pharmacokinetics of anticancer drugs
- Carmichael, S.J.¹

18
- 0034741115
- Modelling and simulation for clinical trial design involving a categorical response. A phase II case study with naratriptan
- in press
- (2001) Pharm. Res.
- Nestorov, I.¹ Graham, G.² Duffull, S.³ Aarons, L.⁴ Fuseau, E.⁵ Coates, P.⁶

19
- 0004075973
- John Wiley and Sons, New York
- (1988) Modern Mathematical Statistics
- Dudewica, E.J.¹ Mishra, S.N.²

20
- 0003593434
- Springer, Paris
- (1997) Identification of Parametric Models from Experimental Data
- Walter, É.¹ Pronzato, L.²

21
- 0002255250
- Design of experiments for estimating enzyme and pharmacokinetic parameters
- Endrenyi L (ed.). Plenum Press, New York
- (1981) Kinetic Data Analysis: Design and Analysis of Enzyme and Pharmacokinetic Experiments , pp. 137-168
- Endrenyi, L.¹

22
- 0003845313
- Clarendon Press, Oxford
- (1992) Optimum Experimental Designs
- Atkinson, A.C.¹ Donev, A.N.²

23
- 0019843944
- Optimal sampling times for pharmacokinetic experiments
- (1981) J. Pharmacokinet. Biopharm. , vol.9 , pp. 739-756
- D'Argenio, D.Z.¹

24
- 0003722417
- Chapman & Hall, London
- (1995) Nonlinear Models for Repeated Measurement Data
- Davidian, M.¹ Giltinan, D.M.²

25
- 0000963178
- Optimal design in random-effects regression models
- (1997) Biometrika , vol.84 , pp. 429-442
- Mentré, F.¹ Mallet, A.² Baccar, D.³

26
- 0032465920
- Robust optimal design for the estimation of hyperparameters in population pharmacokinetics
- (1998) J. Pharmacokinet. Biopharm. , vol.26 , pp. 689-716
- Tod, M.¹ Mentré, F.² Merlé, Y.³ Mallet, A.⁴

27
- 0035107001
- Development and implementation of the population fisher information matrix for the evaluation of population pharmacokinetic designs
- (2001) Comp. Meth. Prog. Biomed. , vol.65 , pp. 141-151
- Retout, S.¹ Duffull, S.² Mentré, F.³

28
- 0027715858
- The importance of modeling interoccasion variability in population pharmacokinetic analyses
- (1993) J. Pharmacokinet. Biopharm. , vol.21 , pp. 735-750
- Karlsson, M.O.¹ Sheiner, L.B.²

29
- 0033130224
- Design of cross-over trials for pharmacokinetic studies
- (1999) J. Stat. Plan. Inf. , vol.78 , pp. 307-316
- Jones, B.¹ Wang, J.² Jarvis, P.³ Byrom, W.⁴

30
- 0006623992
- Constructing optimal designs for fitting pharmacokinetic models
- (1999) Stat. Comp. , vol.8 , pp. 209-218
- Jones, B.¹ Wang, J.²

31
- 0030014455
- Modelling and design of cross-over trials
- (1996) Stat. Med. , vol.15 , pp. 1435-1446
- Jones, B.¹ Donev, A.N.²

32
- 0035049209
- Optimal design of a population pharmacodynamic experiment
- (2001) Pharm. Res. , vol.18 , pp. 83-89
- Duffull, S.B.¹ Mentré, F.² Aarons, L.³

33
- 0002419565
- Design of experiments in nonlinear situations
- (1959) Biometrika , vol.46 , pp. 77-90
- Box, G.E.P.¹ Lucas, H.L.²

34
- 0004264698
- Academic Press, London
- (1972) Theory of Optimal Experiments
- Fedorov, V.V.¹

35
- 0002261164
- Optimal design for individual parameter estimation in pharmacokinetics
- Rowland M, Sheiner LB, Steimer JL (eds). Raven Press, New York
- (1985) Variability in Drug Therapy: Description, Estimation, and Control , pp. 187-199
- Landaw, E.M.¹

36
- 0030174935
- Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteria
- (1996) Comp. Meth. Prog. Biomed. , vol.50 , pp. 13-22
- Tod, M.¹ Rocchisani, J.-M.²

37
- 0025061674
- Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments
- (1990) Math. Biosci. , vol.99 , pp. 105-118
- D'Argenio, D.Z.¹

38
- 0033292350
- Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models
- (1999) J. Pharmacokinet. Biopharm. , vol.27 , pp. 577-596
- Nestorov, I.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.